Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Merck
McKesson
AstraZeneca
McKinsey
Colorcon
Johnson and Johnson

Last Updated: May 19, 2022

Mayne Pharma Inc Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for MAYNE PHARMA INC, and what generic and branded alternatives to MAYNE PHARMA INC drugs are available?

MAYNE PHARMA INC has twenty-six approved drugs.

There is one tentative approval on MAYNE PHARMA INC drugs.

Summary for Mayne Pharma Inc
US Patents:0
Tradenames:22
Ingredients:22
NDAs:26

Drugs and US Patents for Mayne Pharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Inc BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE brompheniramine maleate; dextromethorphan hydrobromide; pseudoephedrine hydrochloride SYRUP;ORAL 207676-001 Dec 4, 2018 AA RX No No See Plans and Pricing See Plans and Pricing
Mayne Pharma Inc HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride SOLUTION;ORAL 205657-001 Aug 3, 2015 DISCN No No See Plans and Pricing See Plans and Pricing
Mayne Pharma Inc OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride TABLET;ORAL 091670-001 Mar 16, 2011 DISCN No No See Plans and Pricing See Plans and Pricing
Mayne Pharma Inc EXEMESTANE exemestane TABLET;ORAL 208764-001 Aug 8, 2019 DISCN No No See Plans and Pricing See Plans and Pricing
Mayne Pharma Inc AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 075389-003 Dec 28, 2017 AB RX No No See Plans and Pricing See Plans and Pricing
Mayne Pharma Inc BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine CAPSULE;ORAL 089007-001 Mar 17, 1986 AA RX No Yes See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
McKinsey
Express Scripts
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.